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The biological clock in cluster headache:
A review and hypothesis
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Patty Doesborg1, Christopher S Colwell3, Michel D Ferrari1 and
Johanna H Meijer4
Abstract
Objective: To review and discuss the putative role of light, sleep, and the biological clock in cluster headache.
Discussion: Cluster headache attacks are believed to be modulated in the hypothalamus; moreover, the severe pain and
typical autonomic cranial features associated with cluster headache are caused by abnormal activity of the trigeminal-
autonomic reflex. The temporal pattern of cluster headache attacks suggests involvement of the biological clock, and the
seasonal pattern is influenced by the number of daylight hours. Although sleep is often reported as a trigger for cluster
headache attacks, to date no clear correlation has been established between these attacks and sleep stage.
Conclusions: We hypothesize that light, sleep, and the biological clock can change the brain’s state, thereby lowering
the threshold for activating the trigeminal-autonomic reflex, resulting in a cluster headache attack. Understanding the
mechanisms that contribute to the daily and seasonal fluctuations in cluster headache attacks may provide new thera-
peutic targets.
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Introduction
Cluster headache is characterized by agonizing headache
attacks with strictly side-locked, excruciating temporal or
intraorbital/periorbital pain lasting anywhere from 15
minutes to 3 hours; these attacks are often accompanied
by ipsilateral autonomic cranial features such as lacrima-
tion, ptosis, miosis, nasal congestion, and/or rhinorrhoea
(1). Cluster headache is one of the so-called trigeminal
autonomic cephalalgias, a class of headache disorders
characterized by brief, side-locked headache attacks
accompanied by cranial autonomic symptoms (1). The
prevalence of cluster headache in the general population
is 1 in 1000 and it is generally more common among men
than among women, with a ratio of 2.5–3.5 to 1 (2).
A fascinating aspect of cluster headache is the currently
unexplained temporal pattern of the attacks. Attacks typ-
ically occur at specific times during the day, and a sea-
sonal rhythm is also common, with attacks occurring
more frequently and/or severely in specific months of
the year (3–5). These temporal patterns have led to the
question of whether the circadian system plays a causal
role in the pathogenesis of cluster headache.
The circadian system is controlled by the suprachias-
matic nuclei (SCN), a bilateral structure located at the
base of the anterior hypothalamus (6). Interestingly,
cluster headache is believed to originate in and/or be
modulated by the hypothalamus and has been treated
using hypothalamic stimulation in patients with severe
forms of cluster headache (7–11). In this review, we
evaluate the putative role of the circadian system in
the onset and frequency of cluster headache attacks.
In episodic cluster headache – the most common
form of the disease – the attacks occur in episodes
with an interval of weeks or months, with remission
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periods lasting several months to years (1). However,
approximately 14% of cluster headache patients do not
have a remission period and therefore suffer from the
chronic form of the disease (12,13). Cluster headache
attacks are associated with autonomic cranial features
and a sense of restlessness and/or agitation (1), symp-
toms that can be explained by hyperactivation of the
trigeminal-autonomic reflex (14), a reflex arch formed
by the facial/greater superficial petrosal nerve dilator
pathway as the efferent and the trigeminal nerve as
the afferent pathway (15). This reflex is activated by
stimulation of the trigeminal ganglion, which results
in vasodilation of the internal carotid arteries through
the release of vasodilator peptides such as calcitonin
gene-related peptide (CGRP), substance P and neuro-
kinin A (16).
During a cluster headache attack, the levels of plasma
CGRP and vasoactive intestinal peptide (VIP) increase,
and dilation of the ipsilateral internal carotid artery and
the resulting increased blood flow have been observed
using magnetic resonance angiography (MRA) and posi-
tron emission tomography (PET), supporting activa-
tion of the trigeminal-autonomic reflex (7,8,17–19).
Furthermore, injecting capsaicin, which is known to trig-
ger the trigeminal-autonomic reflex (20,21), into the fore-
head leads to symptoms similar to a cluster headache
attack (8). It has also been hypothesized that this reflex
underlies the escalation of pain during a cluster headache
attack (22). Interestingly, however, other autonomic
processes such as heart rate, blood pressure, and
autonomic cardiovascular responses do not differ
between patients with cluster headache and control sub-
jects (23).
There is currently no doubt that cluster headache ori-
ginates at the level of the hypothalamus, in contrast to
many other forms of headache. However, there is no
consensus on the area within the hypothalamus, but
most studies point to the posterior hypothalamus.
Specifically, positron emission tomography (PET) and
functional magnetic resonance imaging (fMRI) have
revealed that the ipsilateral inferior posterior hypothal-
amic gray area is activated during cluster headache
attacks (8–10); importantly, this activity is not present
in cluster headache patients during remission periods
(7,8). Activity in other brain areas associated with the
processing of pain, including the thalamus, cingulate
cortex, and insular cortex, has been observed during a
cluster headache attack, as well as during other types of
headache (7,8). In addition, extensive studies of possible
structural differences between cluster headache patients
and control subjects have been performed, and one study
found that the posterior hypothalamus is enlarged in
patients (24). Another study found evidence of enlarge-
ment of the anterior hypothalamus in patients with a
form of trigeminal autonomic cephalalgia (25).The
structural abnormalities in the anterior hypothalamus
of patients are particularly interesting, given that this is
the location of the SCN (i.e. immediately above the optic
chiasm), which generates circadian rhythms (25,26). Two
additional studies found changes in a variety of brain
structures connected to the hypothalamus and in brain
areas related to emotion handling and nociception; how-
ever, neither of these studies found evidence of structural
abnormalities in the hypothalamus (27,28). There are
discrepancies between the hypothalamic imaging studies
that prohibit a clear conclusion at this point. One pos-
sibility is that fMRI/PET do not have sufficient special
resolution, resulting in slightly different outcomes, and/
or the precise location within the hypothalamus that
leads to cluster headache is different among the patient
groups. Additionally, there is no exactly known relation
between an enlarged hypothalamus and its function.
However, the consensus is that the hypothalamus is an
area of great interest in cluster headache, even if the
exact location (i.e. anterior vs. posterior) remains
unclear.
Further evidence supporting a role of the hypothal-
amus in cluster headache comes from a recent report
that deep brain stimulation of the posterior hypothal-
amus improved symptoms in patients with drug-
resistant chronic cluster headache (11). Moreover, lith-
ium is often effective in treating cluster headache. It is
important to note that lithium was one of the first sub-
stances found to affect clock function by lengthening
the circadian period (29). The working mechanism of
lithium for cluster headache remains unknown.
Changes in the hypothalamus, combined with the tem-
poral pattern of cluster headache attacks, suggest that
the central clock of the SCN plays an important role in
cluster headache.
Neurons in the SCN have the autonomous ability to
produce circadian rhythms (26). This rhythmicity at the
single-cell level arises via a negative-feedback loop
between circadian clock genes and their protein prod-
ucts (30). These protein products activate currently
unidentified pathways in order to change the cell’s
membrane potential and electrical frequency (for
review, see (31)). In both nocturnal species (e.g.
rodents) and diurnal species (e.g. humans), elec-
trical activity in the SCN is relatively high during
the day and low during the night (31), creating a wave-
form of electrical activity that is directly correlated
with the animal’s temporal pattern of behavioral
activity (32).
The rhythm of the SCN is synchronized to the exter-
nal light-dark cycle (33). External light is sensed in the
retina by rod and cone photoreceptors and by intrin-
sically photosensitive retinal ganglion cells (ipRGCs);
ipRGCs are directly photosensitive due to the presence
of the photopigment melanopsin (33). The rod and
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cone photoreceptors transmit light information
through the ipRGCs to the ventral SCN via a mono-
synaptic pathway known as the retinohypothalamic
tract (RHT) (33). The release of glutamate and pituit-
ary adenylate cyclase-activating peptide (PACAP) at
RHT terminals triggers an increase in intracellular cal-
cium in the SCN, which changes the rhythm of circa-
dian clock genes (26).
This direct connection between light and the SCN is
interesting, given that hypersensitivity to light – that is,
photophobia – is a symptom that often accompanies
primary headaches (1). Although typically associated
with migraine, photophobia has also been reported to
occur in 45–91% (34,35) of patients with cluster head-
ache. The fact that external light can aggravate head-
ache pain suggests a link between the nociceptive and
optic pathways.
Interestingly, photophobia can still occur in
migraine patients who are visually blind due to a
loss of rod cone and cone cells, but whose retinas
can still detect light (36). In contrast, patients with
blindness due to damage to the optic nerves or the
complete loss of both eyes do not experience photo-
phobia (36). Additionally, these patients do
not exhibit photoentrainment and, in the case of
patients with optic nerve damage but intact eyes,
also do not exhibit pupillary responses (36). The
fact that only visual blind patients experience photo-
phobia suggests that photophobia involves the non-
image-forming pathway mediated by ipRGCs and
melanopsin. This hypothesis is supported by the find-
ing that light evokes melanopsin-dependent neuronal
patterns associated with an experience of aversion in
neonatal mice (37). The precise neuronal circuit that
underlies photophobia is currently unknown; however,
three pathways that can transmit information from
the ipRGCs in the retina to the brain have been
identified.
The first pathway was identified by tracing the
axons of ipRGCs to trigeminal vascular dura-sensitive
neurons in the posterior thalamus (36). These
neurons are modulated by stimulation with light,
thereby representing a retino-thalamo-cortical pathway
by which light can modulate the neuronal activity of
nociception in mice (36). Both fMRI and diffusion
weighted imaging studies indicate that humans also
have a retino-thalamo-cortical tract (38,39). A second
pathway involves the caudal trigeminal complex and is
activated by retinal stimulation (40). Finally, a third
pathway is formed by ipRGCs and/or ipRGC-like mel-
anopsin-containing neurons, which are present in the
iris and retina and project to trigeminal afferents
(41,42). Given the presence of these three – and possibly
more – pathways, understanding the transmission of
information from ipRGCs to the brain may help
identify and characterize the mechanism underlying
photophobia.
In migraine patients, the severity of photophobia
increases with increasing light intensity; however,
whether this is also the case in cluster headache patients
is currently unknown (36). Color is also a determinant
for photophobia; visual blind migraineurs have
observed that blue light worsens their photophobia
(43), and green light has significantly less effect on
migraine compared to other colors such as white,
amber, blue, and red (44); at low intensities, green
light is even considered soothing (44). Interestingly,
the dura-photosensitive trigeminovascular neurons in
the posterior thalamus have the highest response to
blue light and the lowest response to green light (44);
this is particularly relevant given that melanopsin, the
photopigment in ipRGCs, is most sensitive to blue/
green light (45–47). The fact that photophobia is wave-
length-dependent in migraineurs raises the possibility
that the same anatomical pathway might underlie the
photophobia reported in some patients with cluster
headache.
Factors that influence the risk of cluster
headache attacks
Cluster headache is characterized by temporal patterns
of unexplained origin. As illustrated in Figure 1, the
attacks can occur in clusters of weeks to months with
a seasonal rhythm, or they can occur more frequently
and can be more severe in certain months of the year
(3–5). Within a cluster episode, the attacks typically
occur at certain times of the day and/or night. This
rhythmicity of attacks may be due to the effects of
the biological clock and/or sleep.
The day-night cycle
Cluster headache attacks typically occur at predict-
able times (3), and approximately 80% of cluster
headache patients report that their attacks generally
follow a 24-hour cyclical pattern (3,5,48).
Overall, 75% of attacks occur between 9 pm and 10
am (49), with peak incidence at 2 am (3,5,49,50).
The mechanisms that underlie this rhythmicity are cur-
rently unknown. Interestingly, this diurnal cycle
of attacks has been reported to shift by approximately
one hour in women compared to men; however,
other features of diurnal rhythmicity are similar
between sexes (48). A recent genetics study found a
correlation between cluster headache and the
rs12649507 single-nucleotide polymorphism (SNP) in
the CLOCK (Circadian locomotor output cycles
kaput) gene (51). In contrast, no correlation was
found between cluster headache and a polymorphism
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in the PER3 gene or the T-> C polymorphism in the
CLOCK gene (52,53).
Sleep and cluster headache
Although nocturnal sleep is frequently reported as the
most common trigger of cluster headache attacks (23),
one-third of patients also report that napping during
the daytime can trigger attacks (5). Interestingly, most
cluster headache attacks occur within 90 minutes of
falling asleep (54). In addition, many patients anec-
dotally report that they fear going to bed, actively post-
pone sleep, and/or use voluntary sleep deprivation to
avoid experiencing an attack. Moreover, cluster head-
ache patients generally experience poor sleep quality,
even during periods of remission (5). Importantly,
however, both sleep quality and sleep patterns returned
to normal in patients with chronic cluster headache
following successful treatment with deep brain stimula-
tion (55).
Clinically speaking, attacks that begin while awake
do not differ from attacks that begin while asleep (49).
Moreover, studies suggest that attacks are related to
REM sleep, which occurs at the end of the first
90-minute sleep cycle (54,56,57); however, there is cur-
rently no consensus with respect to the putative cor-
relation between various sleep stages and the
occurrence of cluster headache attacks (Table 1)
(58–61). For example, an early study described three
patients whose attacks occurred exclusively during
REM sleep or within 3 minutes after the end of
REM sleep (56), whereas a more recent study found
that 80% of attacks measured during sleep occurred
during non-REM (NREM) sleep (62). Finally,
Barloese et al. reported finding no clear association
between REM sleep or any other sleep stage and clus-
ter headache attacks in 17 patients (63); remarkably,
32 out of the 45 attacks woke the patients from their
sleep (63). Interestingly, both the frequency and dur-
ation of REM sleep are reduced in cluster headache
patients (23,54). Thus, sleep appears to be connected
to cluster headache, the precise association is unclear,
and cluster headache has not yet been clearly corre-
lated with any specific sleep stage. One interesting pos-
sibility is that cluster headache attacks might be
correlated with the transition between sleep stages,
as the ‘‘switch’’ mechanism that underlies this transi-
tion is also located in the hypothalamus (64). Thus,
impaired functioning of this switch might explain why
attacks often occur approximately 90 minutes after the
onset of sleep (when REM sleep begins) and why
attacks tend to occur during – or minutes after –
REM sleep (56). Further research should investigate
this hypothesis.
Hormonal changes
Hormones are closely related to the biological clock, as
the SCN imparts is rhythmic activity to the autonomic
nervous system and the hypothalamic-pituitary-adrenal
axis (65). Moreover, case reports have described pituit-
ary tumors that were believed to cause symptomatic
cluster headache attacks (66,67). Hormonal changes
have been observed in cluster headache patients and
include changes in growth hormone, prolactin, cortisol,
follicle-stimulating hormone (FSH), luteinizing hor-
mone (LH), testosterone, and melatonin levels (68).
The release of the hormone melatonin is inhibited by
light acting via the SCN. Through this influence of
light, the circadian rhythm is synchronized with the
external light-dark cycle and the peak in melatonin
levels occurs during the night (69,70); this nocturnal
peak in melatonin levels is reduced or even absent
in cluster headache patients during an attack period
(71–73) and returns during remission periods (71).
Moreover, melatonin supplements have been reported
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Figure 1. Circadian and seasonal rhythms affect the frequency of cluster headache attacks. (a) The 24-hour day-night rhythm (with
day shown in yellow and night shown in gray) leads to a synchronized 24-hour rhythm in the frequency of cluster headache attacks. (b)
Although the seasonal rhythm (with summer shown in green and winter shown in brown) is less pronounced, many studies indicate
that the pattern of cluster headache attacks is also synchronized to this rhythm.
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to reduce the frequency of attacks in episodic cluster
headache patients, although the therapeutic benefit was
somewhat limited (74,75). In addition, cortisol concen-
trations are elevated during cluster headache attack
periods (76–79). Finally, a nocturnal peak in prolactin
levels often coincides with cluster headache attacks,
whereas prolactin levels are low during remission peri-
ods (80).
Although cluster headache is generally 2.5–3.5-fold
more prevalent among males than among females (2),
the clinical symptoms are similar between men and
women (48,81). The age of onset for cluster headache
ranges from 11 to 40 years, and the prevalence gener-
ally decreases with age (48,50). The gender-biased
nature and age dependency suggest that sex hormones
may play a role in the pathophysiology of cluster head-
ache, although the precise role remains poorly under-
stood. Testosterone levels are often lower in patients
during a cluster headache period (76,79,82–85); this
effect may be secondary to disrupted REM sleep and/
or increased cortisol levels during a cluster headache
period (86,87). With the exceptions of FSH and LH, as
discussed above, no other changes in sex hormones have
been reported in cluster headache patients(79,84), and
other factors that affect hormonal status such as oral
contraceptives, menstruation, pregnancy, and meno-
pause have only a small influence on cluster headache
attacks (88).
The neuropeptides hypocretin-1 and hypocretin-2
play a key role in regulating sleep, maintaining homeo-
stasis, controlling arousal, and processing pain (89).
Interesting, the levels of HCRT-1 in the CSF are
lower in cluster headache patients compared to controls
(63), although these lowered levels are not associated
with the self-reported rhythmicity of cluster headache
attacks (5). A meta-analysis of genetic association
studies revealed that the missense SNP rs2653349 in
the HCRTR2 gene (which encodes HCRT receptor 2)
is associated with a higher risk of cluster headache
(90); however, a more recent analysis failed to repro-
duce this association, indicating that the previous con-
clusion should be interpreted with caution (91).
Nevertheless, the putative role of the HCRT receptor
remains interesting given the episodic nature of cluster
headache.
In summary, several hormones and the neuropeptide
hypocretin have been associated with cluster headache.
However, whether changes in these compounds corres-
pond with changes in their rhythmicity, thus reflecting a
change in the SCN clock and/or its output, remains
unknown. Alternatively, the altered sleep patterns and
stress experience by these patients may explain the
observed hormonal changes.
Circadian clock and cluster headache
The daily rhythmicity in the activity of the SCN follows
a sinusoidal waveform due to the combined electrical
activity of many SCN neurons that are synchronized
but not in perfect phase with one another (92). The
higher number of active neurons during the daytime
creates a peak in electrical activity at midday and a
trough during the night (Figure 2). This pattern of elec-
trical activity is directly correlated with behavioral
activity patterns (32).
The biological clock can play a role in both the
pathogenesis and clinical manifestation of various dis-
eases and conditions. For example, the rhythmic output
of the SCN can influence certain bodily functions,
thereby altering the risk of certain diseases. In some
cases, the clock can affect disease severity without play-
ing a causal role; on the other hand, a malfunction in
Table 1. Overview of data regarding the occurrence of cluster headache attacks during specific sleep stages.
Sleep stage NREM stage (total: 100%)
Author Year Ref
Total number
of attacks REM NREM NREM1 NREM2 NREM3 Unknown
Kudrow et al. 1984 61 19 10 (53%) 9 (47%)
Manzoni et al. 1981 60 2 2 (100%) 0
Zaremba et al. 2012 58 13 0 13 (100%) 3 (23%) 9 (69%) 1 (8%)
Dexter et al. 1970 56 9 5 (55%) 4 (44%)
Pfaffenrath et al. 1986 54 25 5 (20%) 20 (80%) 4 (20%) 11 (55%) 2 (10%) 3 (15%)
Terzaghi et al. 2010 62 5 1 (20%) 4 (80%) 3 (75%) 1 (25%)
Della Marca et al. 2006 59 2 2 (100%) 0
Barloese et al. 2014 63 32 11 (34%) 21 (66%) 2 (10%) 11 (52%) 8 (38%)
Total attacks 107 36 (34%) 71 (66%)
REM: rapid eye movement; NREM: non-REM; NREM1, NREM2, and NREM3: stage 1, stage 2, and stage 3 of NREM sleep, respectively.
Naber et al. 5
the clock’s activity can disrupt the synchrony of cellu-
lar/molecular rhythms in peripheral tissue, giving rise
to various diseases such as metabolic disorders, cardio-
vascular disease, depression, and immune disorders (6).
The circadian system may also play a causal role in
cluster headache, particularly given the daily and sea-
sonal pattern of the attacks and given that the SCN is
located near the hypothalamus, which is believed to
play a role in the onset and/or modulation of cluster
headache attacks.
Seasonal rhythmicity and cluster
headache
More than half of cluster headache patients report that
their attacks have an annual rhythm (23). Typically,
cluster headache is reported to follow an annual pattern
with a peak in the spring (March–April) and a second
peak in autumn (September–October) (3,4,50,81,93).
However, there are some differences in the outcomes
of these studies that seem to depend on the location of
the observed patients. The studies set in California and
in the US show the highest occurrence when days are
shortening or lengthening (3) or shortest and longest (4).
In Norway and Denmark, the lowest incidence system-
atically occurred when the days were longest (5,93). A
study set in Taiwan showed an inverse correlation
between daily sunlight (rather than daylight, which
was not investigated) hours and incidence of cluster
headache periods (94). These findings suggest that the
occurrence of cluster headache attacks is related to the
seasonal changes of daily sunlight. The seasonal rhythm
of cluster headache attacks is more apparent in popula-
tions living further from the equator, where seasonal
rhythms in daylight are stronger.
The biological clock and seasonal rhythmicity
The synchronization of neurons in the SCN appears to
play an important role in encoding seasonal rhythms.
For example, long days tend to reduce this synchroni-
sation, resulting in a lower but broader ensemble peak;
in contrast, shorter days increase synchronization, lead-
ing to a narrower, higher ensemble peak (Figure 3) (95).
The width of the ensemble peak is therefore an internal
reflection of the length of the environmental day (96),
and a change in the width of the peak is the major
mechanism by which the photoperiod, and thus the
season, is encoded by the SCN (96). Certain diseases
and conditions can also have seasonal fluctuations; for
example, seasonal affective disorder is characterized by
seasonal periods of depression that generally start in
autumn/winter and resolve in the spring.
Seasonal changes in hormone levels
In addition to daily rhythms, many hormones also fol-
low a seasonal rhythm. For example, in mammals,
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Figure 2. The central pacemaker in mammals. (a) A coronal mouse brain section stained with Nissl, showing the location of the
suprachiasmatic nuclei (SCN) and optic chiasm (OX). (b) Schematic diagram depicting the electrical activity of individual SCN cells
(shown as blue traces) over a 24-hour period. The SCN cells oscillate slightly out of phase and give rise to the ensemble population
pattern shown in black. This ensemble signal is transmitted to other areas of the brain, thereby providing rhythmicity to the central
nervous system.
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The threshold hypothesis
Factors that influence the disease process of cluster headache
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Figure 4. A hypothetic model to give an overview of factors influencing the disease process of cluster headache. Left: The threshold
hypothesis explains the difference between episodic and chronic cluster headache. Top left: In episodic cluster headache, a fluctuating
disease process causes cluster headache attacks only when the probability exceeds a predetermined threshold (depicted by the horizontal
red line). Bottom left: In chronic cluster headache, the disease process always exceeds this threshold. Right: Central to this hypothesis is
the notion that this threshold can be adjusted by various factors, including the circadian clock, sleep state and hormonal changes.
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Figure 3. Seasonal synchronization of SCN activity. The electrical activity of individual SCN cells is shown in blue, and the ensemble
activity of the SCN is shown in black. (a) During winter, the reduced amount of daily sunlight results in more synchronized firing, giving
rise to a narrow, high-amplitude peak. (b) During summer, the increased amount daily sunlight results in less synchronized firing, giving
rise to a broader peak with a lower amplitude.
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melatonin levels – which are influenced by the SCN –
encode information regarding day length by having a
broader nighttime peak when days become shorter
(97). In many mammals that breed in specific seasons,
this information also affects the production of gonado-
tropic hormones such as FSH and prolactin (98). Studies
in Antarctica showed that the nocturnal peak in mela-
tonin production is delayed in the winter compared to
the summer (99); in contrast, such a delay was not found
in subjects living in Washington, DC; one possible
explanation for this difference may be that the delay in
peak melatonin levels could be suppressed by the pres-
ence of artificial lighting (100).
Lastly, analyses of the annual rhythm of melatonin
revealed lowered concentrations of melatonin in the
urine of cluster headache patients compared to control
subjects (101). On the other hand, the concentration of
melatonin was not influenced by the actual occurrence
of attacks in patients (101).
The threshold hypothesis
The studies described above provide a plethora of clues
suggesting that the biological clock plays a role in the
occurrence of cluster headache attacks. Based on these
data, we propose a threshold-based hypothesis to
explain the temporal patterns of these headaches.
Both chronic and episodic cluster headache appear to
have a fluctuating rhythmicity, resulting in fluctuations
in the probability of a cluster headache attack occur-
ring at a given time, with high probability during a
cluster and low probability outside the cluster. In
patients with chronic cluster headache, this process fol-
lows a rhythmic sinusoidal pattern consisting of more
active and less active periods (Figure 4, bottom). On
the other hand, patients with episodic cluster headache
have a similar sinusoidal pattern, with cluster headache
attacks interspersed with periods of remission, with a
threshold demarking the transition between these peri-
ods; when this threshold is exceeded, the brain enters a
state in which the headaches can occur (Figure 4, top).
We hypothesize that a variety of factors, including
external light, sleep, and the biological clock, can change
the brain’s state, thereby lowering the threshold for acti-
vating the trigeminal-autonomic reflex.With the exception
of the temporal differences in occurrence, the clinical and
demographic characteristics of episodic and chronic clus-
ter headache are strikingly similar. Thus, although epi-
sodic and chronic cluster headache are likely caused by
the same pathophysiological processes, a more ‘‘permis-
sive’’ brain state leads to chronic cluster headache. Based
on this theoretical model, such a threshold could be regu-
lated by factors such as the circadian clock and sleep state.
Conclusions
Cluster headache has a clearly established daily
rhythm, with the frequency of attacks peaking
during the night; the seasonal pattern of cluster head-
ache is also rhythmic but is more variable. These pat-
terns are likely driven either directly or indirectly by
the biological clock. Changes in the daily rhythmicity
of hormones involved in cluster headache have been
reported, although the reports are not consistent. In add-
ition, a relationship between REM sleep and
cluster headache attacks has been reported, but the
evidence for this relationship is not compelling and is
also not consistent. One explanation for the seasonal
rhythmicity of cluster headache attacks is the occurrence
of the summer and winter solstice and the March and
September equinoxes, as well as the amount of daily
sunlight. We propose that episodic and chronic cluster
headache have similar pathophysiological mechanisms,
and changes in the brain’s state can reduce the threshold
for activating the trigeminal-autonomic reflex, thereby
giving rise to the chronic form of cluster headache. An
important implication for the threshold hypothesis is
that chronic cluster headache can turn into episodic clus-
ter headache (and vice versa) in a given patient. We also
suggest that various factors, including sleep, light, and
particularly the biological clock, can influence the
threshold for experiencing a cluster headache attack.
Future studies should be designed to help elucidate the
relative contributions of these putative factors to the
susceptibility of cluster headache attacks. The insights
gained from these studies would provide an important
starting point for more mechanism-based studies of clus-
ter headache and would likely help facilitate the devel-
opment of new therapeutic strategies.
Abbreviations
CGRP Calcitonin gene-related peptide
CLOCK Circadian locomotor output cycles kaput
fMRI Functional magnetic resonance imaging
HCRT Hypocretin
HCRT2 Hypocretin receptor 2
IpRGCs Intrinsically photosensitive retinal ganglion
cells
MRA Magnetic resonance angiography
PACAP Pituitary adenylate cyclase-activating peptide
PET Positron emission tomography
RHT Retinohypothalamic tract
SCN Suprachiasmatic nucleus
SHBG Sex hormone-binding globulin
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TRH Thyrotropin-releasing hormone
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Article highlights
. The biological clock plays a role in both the occurrence and severity of cluster headache attacks.
. Although sleep has been reported as a trigger for cluster headache attacks, the precise relationship between
sleep stage and cluster headache is currently unknown.
. The seasonal pattern of cluster headache attacks may be influenced by the amount of daily sunlight and
appears to vary with latitude.
. The precise mechanistic role that the circadian clock plays in cluster headache requires further study in order
to facilitate the development of more effective therapeutic approaches.
. On the basis of the ‘‘threshold hypothesis’’, we propose that the same mechanism accounts for episodic and
chronic cluster headache.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.
Funding
The authors received no financial support for the research,
authorship, and/or publication of this article.
References
1. Headache Classification Committee of the International
Headache Society. The International Classification of
Headache Disorders, 3rd edition. Cephalalgia 2018; 38:
1–211.
2. Nesbitt AD and Goadsby PJ. Cluster headache. BMJ
2012; 344: e2407–e2407.
3. Rozen TD and Fishman RS. Cluster headache in the
United States of America: Demographics, clinical char-
acteristics, triggers, suicidality, and personal burden.
Headache 2012; 52: 99–113.
4. Kudrow L. The cyclic relationship of natural illumination
to cluster period frequency. Cephalalgia 1987; 7: S76–S78.
5. Barloese M, Lund N, Petersen A, et al. Sleep and chrono-
biology in cluster headache. Cephalalgia 2015; 35:
969–978.
6. Colwell CS. Circadian medicine. Hoboken, NJ: John
Wiley & Sons, 2015, p.376.
7. May A, Bahra A, Buchel C, et al. Hypothalamic activa-
tion in cluster headache attacks. Lancet 1998; 352:
275–278.
8. May A, Bahra A, Buchel C, et al. PET and MRA findings
in cluster headache and MRA in experimental pain.
Neurology 2000; 55: 1328–1335.
9. Morelli N, Pesaresi I, Cafforio G, et al. Functional mag-
netic resonance imaging in episodic cluster headache.
J Headache Pain 2009; 10: 11–14.
10. Sprenger T, Boecker H, Tolle TR, et al. Specific hypo-
thalamic activation during a spontaneous cluster head-
ache attack. Neurology 2004; 62: 516–517.
11. Leone M and Proietti Cecchini A. Deep brain stimulation
in headache. Cephalalgia 2016; 36: 1143–1148.
12. Favier I, Haan J and Ferrari MD. Chronic cluster head-
ache: A review. J Headache Pain 2005; 6: 3–9.
13. Fischera M, Marziniak M, Gralow I, et al. The inci-
dence and prevalence of cluster headache: A meta-analy-
sis of population-based studies. Cephalalgia 2008; 28:
614–618.
14. Goadsby PJ. Pathophysiology of cluster headache: A tri-
geminal autonomic cephalgia. Lancet Neurol 2002; 1:
251–257.
15. Goadsby PJ, Lambert GA and Lance JW. Stimulation of
the trigeminal ganglion increases flow in the extracerebral
but not the cerebral circulation of the monkey. Brain Res
1986; 381: 63–67.
16. Tran Dinh YR, Thurel C, Cunin G, et al. Cerebral vaso-
dilation after the thermocoagulation of the trigeminal
ganglion in humans. Neurosurgery 1992; 31: 658–663.
17. Goadsby PJ and Edvinsson L. Human in vivo evidence
for trigeminovascular activation in cluster headache.
Neuropeptide changes and effects of acute attacks thera-
pies. Brain 1994; 117: 427–434.
18. Edvinsson L and Goadsby PJ. Neuropeptides in
migraine and cluster headache. Cephalalgia 1994; 14:
320–327.
19. Fanciullacci M, Alessandri M, Figini M, et al. Increase in
plasma calcitonin gene-related peptide from the extracer-
ebral circulation during nitroglycerin-induced cluster
headache attack. Pain 1995; 60: 119–123.
20. May A, Buchel C, Turner R, et al. Magnetic resonance
angiography in facial and other pain: Neurovascular
mechanisms of trigeminal sensation. J Cereb Blood Flow
Metab 2001; 21: 1171–1176.
21. May A, Kaube H, Bu¨chel C, et al. Experimental cranial
pain elicited by capsaicin: A PET study. Pain 1998; 74:
61–66.
22. Drummond PD. Mechanisms of autonomic disturbance
in the face during and between attacks of cluster head-
ache. Cephalalgia 2006; 26: 633–641.
23. Barloese MC. Neurobiology and sleep disorders in cluster
headache. J Headache Pain 2015; 16: 562.
24. May A, Ashburner J, Buchel C, et al. Correlation
between structural and functional changes in brain in
an idiopathic headache syndrome. Nat Med 1999; 5:
836–838.
Naber et al. 9
25. Arkink EB, Schmitz N, Schoonman GG, et al. The anter-
ior hypothalamus in cluster headache. Cephalalgia 2017;
37: 1039–1050.
26. Welsh DK, Takahashi JS and Kay SA. Suprachiasmatic
nucleus: Cell autonomy and network properties. Annu
Rev Physiol 2010; 72: 551–577.
27. Absinta M, Rocca MA, Colombo B, et al. Selective
decreased grey matter volume of the pain-matrix network
in cluster headache. Cephalalgia 2012; 32: 109–115.
28. Yang FC, Chou KH, Fuh JL, et al. Altered gray
matter volume in the frontal pain modulation network
in patients with cluster headache. Pain 2013; 154:
801–807.
29. Li J, Lu WQ, Beesley S, et al. Lithium impacts on the
amplitude and period of the molecular circadian clock-
work. PloS One 2012; 7: e33292.
30. Takahashi JS. Transcriptional architecture of the mam-
malian circadian clock. Nat Rev Gen 2017; 18: 164–179.
31. Allen CN, Nitabach MN and Colwell CS. Membrane
currents, gene expression, and circadian clocks. Cold
Spring Harb Perspect 2017; 9: a027714.
32. Houben T, Coomans CP and Meijer JH. Regulation of
circadian and acute activity levels by the murine supra-
chiasmatic nuclei. PloS One 2014; 9: e110172.
33. LeGates TA, Fernandez DC and Hattar S. Light as a
central modulator of circadian rhythms, sleep and
affect. Nat Rev Neurosci 2014; 15: 443–454.
34. Taga A, Russo M, Manzoni GC, et al. Cluster headache
with accompanying migraine-like features: A possible
clinical phenotype. Headache 2017; 57: 290–297.
35. Vingen JV, Pareja JA and Stovner LJ. Quantitative
evaluation of photophobia and phonophobia in cluster
headache. Cephalalgia 1998; 18: 250–256.
36. Noseda R, Kainz V, Jakubowski M, et al. A neural mech-
anism for exacerbation of headache by light. Nature
Neurosci 2010; 13: 239–245.
37. Delwig A, Logan AM, Copenhagen DR, et al. Light
evokes melanopsin-dependent vocalization and neural
activation associated with aversive experience in neonatal
mice. PloS One 2012; 7: e43787.
38. Maleki N, Becerra L, Upadhyay J, et al. Direct optic
nerve pulvinar connections defined by diffusion MR trac-
tography in humans: Implications for photophobia. Hum
Brain Mapp 2012; 33: 75–88.
39. Burstein R, Jakubowski M, Garcia-Nicas E, et al. Tha-
lamic sensitization transforms localized pain into wide-
spread allodynia. Ann Neurol 2010; 68: 81–91.
40. Okamoto K, Thompson R, Tashiro A, et al. Bright light
produces Fos-positive neurons in caudal trigeminal
brainstem. Neuroscience 2009; 160: 858–864.
41. Dolgonos S, Ayyala H and Evinger C. Light-induced
trigeminal sensitization without central visual pathways:
Another mechanism for photophobia. Invest Ophthalmol
Vis Sci 2011; 52: 7852–7858.
42. Xue T, Do MTH, Riccio A, et al. Melanopsin signalling
in mammalian iris and retina. Nature 2011; 479: 67–73.
43. Zaidi FH, Hull JT, Peirson SN, et al. Short-wavelength
light sensitivity of circadian, pupillary, and visual aware-
ness in humans lacking an outer retina. Curr Biol 2007;
17: 2122–2128.
44. Noseda R, Bernstein CA, Nir RR, et al. Migraine photo-
phobia originating in cone-driven retinal pathways. Brain
2016; 139: 1971–1986.
45. Berson DM, Dunn FA and Takao M. Phototransduction
by retinal ganglion cells that set the circadian clock.
Science 2002; 295: 1070–1073.
46. Hattar S, Lucas RJ, Mrosovsky N, et al. Melanopsin and
rod-cone photoreceptive systems account for all major
accessory visual functions in mice. Nature 2003; 424:
76–81.
47. Lucas RJ, Douglas RH and Foster RG. Characterization
of an ocular photopigment capable of driving pupillary
constriction in mice. Nat Neurosci 2001; 4: 621–626.
48. LundN, BarloeseM, Petersen A, et al. Chronobiology dif-
fers between men and women with cluster headache, clin-
ical phenotype does not. Neurology 2017; 88: 1069–1076.
49. Russell D. Cluster headache: Severity and temporal pro-
files of attacks and patient activity prior to and during
attacks. Cephalalgia 1981; 1: 209–216.
50. Manzoni GC, Terzano MG, Bono G, et al. Cluster head-
ache – clinical findings in 180 patients. Cephalalgia 1983;
3: 21–30.
51. Fourier C, Ran C, Zinnegger M, et al. A genetic CLOCK
variant associated with cluster headache causing
increased mRNA levels. Cephalalgia 2018; 38: 496–502.
52. Ofte HK, Tronvik E and Alstadhaug KB. Lack of asso-
ciation between cluster headache and PER3 clock gene
polymorphism. J Headache Pain 2015; 17: 18.
53. Rainero I, Rivoiro C, Gallone S, et al. Lack of associ-
ation between the 3092 T–>C Clock gene polymorphism
and cluster headache. Cephalalgia 2005; 25: 1078–1081.
54. Pfaffenrath V, Po¨llmann W, Ru¨ther E, et al. Onset of
nocturnal attacks of chronic cluster headache in relation
to sleep stages. Act Neurol Scand 1986; 73: 403–407.
55. Kovac S, Wright M-A, Eriksson SH, et al. The effect of
posterior hypothalamus region deep brain stimulation on
sleep. Cephalalgia 2014; 34: 219–223.
56. Dexter JD and Weitzman ED. The relationship of noc-
turnal headaches to sleep stage patterns. Neurology 1970;
20: 513–518.
57. Kayed K, Godtlibsen OB and Sjaastad O. Chronic par-
oxysmal hemicrania IV: ‘‘REM sleep locked’’ nocturnal
headache attacks. Sleep 1978; 1: 91–95.
58. Zaremba S, Holle D, Wessendorf TE, et al. Cluster head-
ache shows no association with rapid eye movement
sleep. Cephalalgia 2012; 32: 289–296.
59. Della Marca G, Vollono C, Rubino M, et al. A sleep
study in cluster headache. Cephalalgia 2006; 26: 290–294.
60. Manzoni GC, Terzano MG, Moretti G, et al. Clinical
observations on 76 cluster headache cases. Eur Neurol
1981; 20: 88–94.
61. Kudrow L, McGinty DJ, Phillips ER, et al. Sleep apnea
in cluster headache. Cephalalgia 1984; 4: 33–38.
62. Terzaghi M, Ghiotto N, Sances G, et al. Episodic cluster
headache: NREM prevalence of nocturnal attacks.
Time to look beyond macrostructural analysis?
Headache 2010; 50: 1050–1054.
63. Barloese MC, Jennum PJ, Lund NT, et al. Sleep in cluster
headache – beyond a temporal rapid eye movement rela-
tionship? Eur Neurol 2015; 22: 656–664.
10 Cephalalgia 0(0)
64. Lu J, Sherman D, Devor M, et al. A putative flip-flop
switch for control of REM sleep. Nature 2006; 441:
589–594.
65. Perreau-Lenz S, Pe´vet P, Buijs RM, et al. The biological
clock: The bodyguard of temporal homeostasis.
Chronobio Int 2004; 21: 1–25.
66. de Coo IF, Wilbrink LA and Haan J. Symptomatic tri-
geminal autonomic cephalalgias. Curr Pain Headache
Rep 2015; 19: 39.
67. Wilbrink LA, Ferrari MD, Kruit MC, et al. Neuroima-
ging in trigeminal autonomic cephalgias: When, how, and
of what? Curr Opin Neurol 2009; 22: 247–253.
68. Leone M and Bussone G. A review of hormonal findings
in cluster headache. Evidence for hypothalamic involve-
ment. Cephalalgia 1993; 13: 309–317.
69. Illnerova´ H and Sumova´ A. Photic entrainment of the
mammalian rhythm in melatonin production. J Biol
Rhythms 1997; 12: 547–555.
70. Johnston JD and Skene DJ. 60 years of neuroendocrinol-
ogy: Regulation of mammalian neuroendocrine physi-
ology and rhythms by melatonin. J Endocrinol 2015;
226: T187–T198.
71. Bruera O, Sances G, Leston J, et al. Plasma mela-
tonin pattern in chronic and episodic headaches: Evalua-
tion during sleep and waking. Funct Neurol 2008; 23:
77–81.
72. Waldenlind E, Gustafsson SA, Ekbom K, et al. Circadian
secretion of cortisol and melatonin in cluster headache
during active cluster periods and remission. J Neurol
Neurosurg Psychiatry 1987; 50: 207–213.
73. Chazot G, Claustrat B, Brun J, et al. A chronobiological
study of melatonin, cortisol growth hormone and prolac-
tin secretion in cluster headache. Cephalalgia 1984; 4:
213–220.
74. Leone M, D’Amico D, Moschiano F, et al. Melatonin
versus placebo in the prophylaxis of cluster headache:
A double-blind pilot study with parallel groups.
Cephalalgia 1996; 16: 494–496.
75. Pringsheim T, Magnoux E, Dobson CF, et al.
Melatonin as adjunctive therapy in the prophylaxis of
cluster headache: A pilot study. Headache 2002; 42:
787–792.
76. Facchinetti F, Nappi G, Cicoli C, et al. Reduced testos-
terone levels in cluster headache: A stress-related phe-
nomenon? Cephalalgia 1986; 6: 29–34.
77. Leone M, Zappacosta BM, Valentini S, et al. The insulin
tolerance test and the ovine corticotrophin-releasing hor-
mone test in episodic cluster headache. Cephalalgia 1991;
11: 269–274.
78. Meyer EL, Marcus C and Waldenlind E. Nocturnal
secretion of growth hormone, noradrenaline, cortisol
and insulin in cluster headache remission. Cephalalgia
2007; 27: 912–919.
79. Waldenlind E and Gustafsson SA. Prolactin in cluster
headache: Diurnal secretion, response to thyrotropin-
releasing hormone, and relation to sex steroids and
gonadotropins. Cephalalgia 1987; 7: 43–54.
80. Levi R, Edman GV, Ekbom K, et al. Episodic cluster
headache. II: High tobacco and alcohol consumption in
males. Headache 1992; 32: 184–187.
81. Bahra A, May A and Goadsby PJ. Cluster headache: A
prospective clinical study with diagnostic implications.
Neurology 2002; 58: 354–361.
82. Klimek A. Plasma testosterone levels in patients with
cluster headache. Headache 1982; 22: 162–164.
83. Kudrow L. Plasma testosterone levels in cluster headache
preliminary results. Headache 1976; 16: 28–31.
84. Murialdo G, Fanciullacci M, Nicolodi M, et al. Cluster
headache in the male: Sex steroid pattern and gonado-
tropic response to luteinizing hormone releasing hor-
mone. Cephalalgia 1989; 9: 91–98.
85. Romiti A, Martelletti P, Gallo MF, et al. Low plasma
testosterone levels in cluster headache. Cephalalgia 1983;
3: 41–44.
86. Evans JI, Maclean AM, Ismail AA, et al. Circulating
levels of plasma testosterone during sleep. Proc R Soc
Med 1971; 64: 841–842.
87. Micieli G, Facchinetti F, Martignoni E, et al. Disordered
pulsatile LH release in cluster headache. Cephalalgia
1987; 7: S79–S81.
88. van Vliet JA, Favier I, Helmerhorst FM, et al. Cluster
headache in women: Relation with menstruation, use of
oral contraceptives, pregnancy, and menopause. J Neurol
Neurosurg Psychiatry 2006; 77: 690–692.
89. Sakurai T. The neural circuit of orexin (hypocretin):
Maintaining sleep and wakefulness. Nat Rev Neurosci
2007; 8: 171–181.
90. Rainero I, Rubino E, Valfre W, et al. Association
between the G1246A polymorphism of the hypocretin
receptor 2 gene and cluster headache: A meta-analysis.
J Headache Pain 2007; 8: 152–156.
91. Weller CM, Wilbrink LA, Houwing-Duistermaat JJ,
et al. Cluster headache and the hypocretin receptor 2
reconsidered: A genetic association study and meta-ana-
lysis. Cephalalgia 2015; 35: 741–747.
92. Schaap J, Albus H, VanderLeest HT, et al. Heterogeneity
of rhythmic suprachiasmatic nucleus neurons: Implica-
tions for circadian waveform and photoperiodic encod-
ing. Proc Natl Acad Sci USA 2003; 100: 15994–15999.
93. Ofte HK, Berg DH, Bekkelund SI, et al. Insomnia and
periodicity of headache in an arctic cluster headache
population. Headache 2013; 53: 1602–1612.
94. Lin KH, Wang PJ, Fuh JL, et al. Cluster headache in the
Taiwanese – a clinic-based study. Cephalalgia 2004; 24:
631–638.
95. VanderLeest HT, Houben T, Michel S, et al. Seasonal
encoding by the circadian pacemaker of the SCN. Curr
Biol 2007; 17: 468–473.
96. Meijer JH, Colwell CS, Rohling JH, et al. Dynamic neur-
onal network organization of the circadian clock and
possible deterioration in disease. Prog Brain Res 2012;
199: 143–162.
97. Matthews CD, Seamark RF and Guerin MV. Plasma
melatonin profiles of Romney Marsh sheep in natural
photoperiod and in acutely extended darkness. J Reprod
Fertil 1992; 95: 869–875.
98. Jorgenson KL and Schwartz NB. Shifts in gonadotropin
and steroid levels that precede anestrus in female golden
hamsters exposed to a short photoperiod. Biol Reprod
1985; 32: 611–618.
Naber et al. 11
99. Yoneyama S, Hashimoto S and Honma K. Seasonal
changes of human circadian rhythms in Antarctica.
Am J Physiol 1999; 277: R1091–R1097.
100. Wehr TA, Giesen HA, Moul DE, et al. Suppression of
men’s responses to seasonal changes in day length by
modern artificial lighting. Am J Physiol 1995; 269:
R173–R178.
101. Waldenlind E, Ekbom K, Wetterberg L, et al. Lowered
circannual urinary melatonin concentrations in episodic
cluster headache. Cephalalgia 1994; 14: 199–204.
12 Cephalalgia 0(0)
